Discovery of small molecule therapeutics for the Middle Eastern respiratory syndrome-coronavirus (MERS-CoV)
Middle-Eastern Respiratory Syndrome (MERS) is a coronavirus infection which affects the lower respiratory tract of infected individuals. Its high mortality rate of 34.5% led MERS to be listed as a high priority disease for research by the World Health Organisation (WHO). MERS can be both symptomatic...
Main Author: | Gan, Jonathan Hanjie |
---|---|
Other Authors: | Yoon Ho Sup |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/137291 |
Similar Items
-
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
by: Ahmed Mostafa, et al.
Published: (2020-07-01) -
Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug
by: Gan, Hanjie Jonathan, et al.
Published: (2022) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Seropositive Camel Handlers in Kenya
by: Alice N. Kiyong’a, et al.
Published: (2020-04-01) -
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is Not Circulating Among Hajj Pilgrims
by: Jaffar A. Al-Tawfiq, et al.
Published: (2023-06-01) -
The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters.
by: Emmie de Wit, et al.
Published: (2013-01-01)